Effective close of trading last December 28, 2006, shares of
The merger of these two companies (Stiefel and Connetics) unites the innovative skin care products and commercial capabilities of Stiefel Laboratories with the advanced therapies and patented drug-delivery technologies of Connetics resulting in one of the most robust and diverse dermatology product lines in the industry.
Thus, reinforcing the commitment of Stiefel Laboratories to the advancement of dermatology globally and creating one of the largest dermatology product pipelines in the world, merging technology and development expertise to yield significant advancements in the treatment of skin conditions.
The Global Headquarters of Stiefel Laboratories will remain in Coral Gables,Source: Stiefel Laboratories, Inc.
.jpg)
Comment Preview